290
Participants
Start Date
June 30, 2016
Primary Completion Date
September 30, 2022
Study Completion Date
September 30, 2022
Mistletoe extract (Iscador Qu)
1ml subcutaneous injection 3 times/week, dose escalation 0,01mg - 20mg
Placebo
1ml subcutaneous injection 3 times/week
Kathrin Wode, Stockholm
University of Witten/Herdecke
OTHER
Karolinska Institutet
OTHER
Regional Cancer Centre Stockholm Gotland
OTHER
Stiftelsen Konung Gustaf V:s Jubileumsfond för cancerforskning
UNKNOWN
Signe & Ane Gyllenbergs Stiftelse
UNKNOWN
Ekhagastiftelsen
OTHER
Dagmar Ferbs Minnesfond
UNKNOWN
Cancerforskningsfonden i Norrland
UNKNOWN
Immunpathologisches Labor, University Tübingen
UNKNOWN
The Sjöberg Foundation
UNKNOWN
Karolinska University Hospital
OTHER